CLDX 8-K 2026-09-22

Celldex Therapeutics, Inc. (CLDX) 8-K dated 2026-09-22 — accession 0001104659-26-109465. This URL is the filing, not the CLDX hub.

Celldex Therapeutics, Inc. (CLDX) is a biotechnology company listed on US.

Celldex Therapeutics, Inc. filed a 8-K on 2026-09-22. Accession 0001104659-26-109465.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CLDX revenue for 2026-06-30 was $22.0K. Net income was -$73.5M. Revenue was up 46.7% from 2026-03-31 to 2026-06-30. CLDX currently screens at market cap $2.35B.

Not investment advice. The CLDX SEC hub lists recent forms. The stock page is the research view.